At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 254 enrolled
Drug / intervention
Naproxen Test +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Naproxen [Test] Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars
In Brief
A Phase 2 clinical trial evaluating Naproxen Test, Naprosyn, and 1 other intervention for Dental Pain. Completed, enrolled 254 participants across 1 site.
Detailed Summary
The purpose of the study is to determine whether Naproxen Test Formulation Capsules are safe and effective for the treatment of dental pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedOct 2010
Primary CompletionApr 2011
TodayJul 2026
First PostedOct 27, 2010
Enrollment StartOct 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.7 years ago
Interventions
Naproxen Testdrug
200-mg single dose
Naproxen Testdrug
400-mg (2 x 200-mg)
Naprosyndrug
single dose
Naprosyndrug
single dose
Placebodrug
single dose